Preventable delays in the treatment of intraocular melanoma in the UK

Eye

Volumn 10, Issue 1, 1996, Pages 127-129

  Holden, Roger ^a,b   Damato, Bertil E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

Delay; Intraocular; Melanoma; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; DIAGNOSTIC ERROR; EYE CANCER; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OPHTHALMOSCOPY; SYMPTOM; TIME; UNITED KINGDOM; VISION; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 0030008113     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.22     Document Type: Article

References (9)

1. Scotto J, Fraumeni JF, Lee JAH. Melanomas of the eye and other non-cutaneous sites: epidemiological aspects. J Natl Cancer Inst 1976;56:489-91.
2. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiological aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
3. Raivio I. Uveal melanoma in Finland: an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl 1977;133:3-64.
4. Jensen OA. Malignant melanomas of the human uvea: 25 year follow-up of cases in Denmark, 1942-1952. Acta Ophthalmol (Copenh) 1982;60:161-82.
5. Shields JA. Management of uveal melanoma: a continuing dilemma. Cancer 1993;72:2067-8.
6. Damato BE. An approach to the management of patients with uveal melanoma. Eye 1993;7:388-97.
7. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990;97:769-77.
8. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979;87:741-60.
9. Char DH, Stone RD, Irvine AR, Crawford JB, Hilton GF, Lonn LI, Schwartz A. Diagnostic modalities in choroidal melanoma. Am J Ophthalmol 1980;89:223-30.